Layerwave Bio is a developer of IVD diagnostic instrument reagents and biomedical scientific research instruments. The company focuses on the field of flow cytometry, and is committed to realizing the automation and routineization of flow technology, and the foolish and intelligent application analysis. Recently, Layerwave Bio announced the completion of tens of millions of yuan in Series A financing. This round of financing was invested by IDG Capital, and the funds will be used for the research and development and marketing of the company’s flow cytometry products.
This article is reproduced from: https://www.itjuzi.com/investevent/13414796
This site is for inclusion only, and the copyright belongs to the original author.